Po‐wai Yuen

2.2k citations

24 papers · 1.3k indexed · h-index 15

Molecular Biology top 10%
Cell Biology top 2%
Cellular and Molecular Neuroscience top 5%
Genetics
Physiology

Co-authors: Kevin Wang Rathna Nath Kadee J. Raser Avigail Posner Iradj Hajimohammadreza Richard B. Gilbertsen Robert V. Talanian Daniel Stafford
Topics: Calpain Protease Function and Regulation (10 papers)Neuroscience and Neuropharmacology Research (5 papers)Sirtuins and Resveratrol in Medicine (4 papers)
Cited by: Cell Biology Geriatrics and Gerontology Cellular and Molecular Neuroscience
Journals: Proceedings of the National Academy of Sciences Biochemical Journal Journal of Medicinal Chemistry
Partner nations: United States Japan Poland

In The Last Decade

Po‐wai Yuen

24 papers receiving 1.3k citations

Peers

Countries citing papers authored by Po‐wai Yuen

Since Specialization

Citations

This map shows the geographic impact of Po‐wai Yuen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐wai Yuen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐wai Yuen more than expected).

Fields of papers citing papers by Po‐wai Yuen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po‐wai Yuen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐wai Yuen. The network helps show where Po‐wai Yuen may publish in the future.

Co-authorship network of co-authors of Po‐wai Yuen

This figure shows the co-authorship network connecting the top 25 collaborators of Po‐wai Yuen. A scholar is included among the top collaborators of Po‐wai Yuen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po‐wai Yuen. Po‐wai Yuen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aminoisoxazoles as Potent Inhibitors of Tryptophan 2,3-Dioxygenase 2 (TDO2) 2018 ·ACS Medicinal Chemistry Letters ·Zhonghua Pei,Rohan Mendonca,Lewis Gazzard,Richard Pastor,(unknown),Amy Gustafson,Erica C. VanderPorten,Georgia Hatzivassiliou,Kevin DeMent,Robert Cass,Po‐wai Yuen,Yamin Zhang,Guosheng Wu,Xingyu Lin,Yichin Liu,Benjamin D. Sellers	34
2	Minimizing CYP2C9 Inhibition of Exposed-Pyridine NAMPT (Nicotinamide Phosphoribosyltransferase) Inhibitors 2016 ·Journal of Medicinal Chemistry ·Mark Zak,Po‐wai Yuen,(unknown),Snahel Patel,Deepak Sampath,Jason Oeh,Bianca M. Liederer,Weiru Wang,Thomas O’Brien,Yang Xiao,Nicholas J. Skelton,(unknown),Jasleen K. Sodhi,Yunli Wang,Lei Zhang,Gui‐Ling Zhao,Xiaozhang Zheng,Yen‐Ching Ho,Kenneth W. Bair,Peter S. Dragovich	26
3	Structural and Biochemical Analyses of the Catalysis and Potency Impact of Inhibitor Phosphoribosylation by Human Nicotinamide Phosphoribosyltransferase 2014 ·ChemBioChem ·Angela Oh,Yen‐Ching Ho,Mark Zak,Yongbo Liu,(unknown),Po‐wai Yuen,Xiaozhang Zheng,Yichin Liu,Peter S. Dragovich,Weiru Wang	37
4	Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived ureas as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT) 2013 ·Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich,Kenneth W. Bair,(unknown),Yen‐Ching Ho,Bianca M. Liederer,(unknown),Yongbo Liu,Thomas O’Brien,Jason Oeh,Deepak Sampath,Nicholas J. Skelton,(unknown),Weiru Wang,(unknown),Yang Xiao,Po‐wai Yuen,Mark Zak,Lei Zhang,Xiaozhang Zheng	22
5	Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Xiaozhang Zheng,(unknown),Alexandre J. Buckmelter,Maureen Caligiuri,Karl H. Clodfelter,Bingsong Han,Yen‐Ching Ho,Nikolai Kley,Jian Lin,Dominic J. Reynolds,Geeta Sharma,Chase C. Smith,Zhongguo Wang,Peter S. Dragovich,Angela Oh,Weiru Wang,Mark Zak,Yunli Wang,Po‐wai Yuen,Kenneth W. Bair	13
6	Chemistry and Pharmacology of Nicotinic Ligands Based on 6‐[5‐(Azetidin‐2‐ylmethoxy)pyridin‐3‐yl]hex‐5‐yn‐1‐ol (AMOP‐H‐OH) for Possible Use in Depression 2009 ·ChemMedChem ·Alan P. Kozikowski,J. Brek Eaton,Krishna Bajjuri,(unknown),Yihua Chen,(unknown),Rong He,Barbara J. Caldarone,(unknown),Po‐wai Yuen,Ronald J. Lukas	33
7	The Novel Calpain Inhibitor SJA6017 Improves Functional Outcome after Delayed Administration in a Mouse Model of Diffuse Brain Injury 2001 ·Journal of Neurotrauma ·Nancy C. Kupina,Rathna Nath,(unknown),Jun Inoue,(unknown),Po‐wai Yuen,Kevin Wang,Edward D. Hall	94
8	ChemInform Abstract: Subtype‐Selective N‐Methyl‐D‐aspartate Receptor Antagonists: Benzimidazolone and Hydantoin as Phenol Replacements. 2000 ·ChemInform ·(unknown),Po‐wai Yuen,Kevin A. Serpa,Leonard T. Meltzer,Lawrence D. Wise,Edward R. Whittemore,Richard M. Woodward	3
9	Structure−Activity Relationship of N-(Phenylalkyl)cinnamides as Novel NR2B Subtype-Selective NMDA Receptor Antagonists 1999 ·Journal of Medicinal Chemistry ·Amir P. Tamiz,Sui Xiong Cai,Zhang‐Lin Zhou,Po‐wai Yuen,(unknown),Edward R. Whittemore,Eckard Weber,Richard M. Woodward,John F. W. Keana	37
10	Calpain : pharmacology and toxicology of calcium-dependent protease 1999 ·Taylor & Francis eBooks ·Kevin Wang,Po‐wai Yuen	80
11	N-(2-(4-hydroxyphenyl)ethyl)-4-chlorocinnamide: A novel antagonist at the 1a/2B NMDA receptor subtype 1998 ·Bioorganic & Medicinal Chemistry Letters ·Amir P. Tamiz,Edward R. Whittemore,(unknown),Po‐wai Yuen,Richard M. Woodward,(unknown),Eckard Weber,John F. W. Keana	11
12	Synthesis and structure-activity relationship of substituted 1,2,3,4-tetrahydroisoquinolines as N-type calcium channel blockers 1998 ·Bioorganic & Medicinal Chemistry Letters ·Po‐wai Yuen,(unknown),Balázs Szőke,Katalin Tarczy‐Hornoch	8
13	Calpain inhibitors: Novel neuroprotectants and potential anticataract agents 1998 ·Drugs of the Future ·Po‐wai Yuen,Kevin Wang	24
14	Crystal structure of calcium bound domain VI of calpain at 1.9 Å resolution and its role in enzyme assembly, regulation, and inhibitor binding 1997 ·Nature Structural Biology ·G. Lin,Debasish Chattopadhyay,Masatoshi Maki,Kevin Wang,Mike Carson,Lei Jin,Po‐wai Yuen,Emiko Takano,(unknown),(unknown),Sthanam V.L. Narayana	157
15	Novel Use of Substituted 1,4-Dihydrobenz[d][1,3]oxazin-2-ones in the Synthesis of Important Aminomethyl o-Nitroanilines 1997 ·The Journal of Organic Chemistry ·Sham S. Nikam,Po‐wai Yuen,(unknown),Brian Tobias,Michael Rafferty	9
16	Non-erythroid α-spectrin breakdown by calpain and interleukin 1 β-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis 1996 ·Biochemical Journal ·Rathna Nath,Kadee J. Raser,Daniel Stafford,Iradj Hajimohammadreza,Avigail Posner,Hamish Allen,Robert V. Talanian,Po‐wai Yuen,Richard B. Gilbertsen,Kevin Wang	396
17	An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. 1996 ·Proceedings of the National Academy of Sciences ·Kevin Wang,Rathna Nath,Avigail Posner,Kadee J. Raser,(unknown),Iradj Hajimohammadreza,(unknown),(unknown),(unknown),Emiko Takano,Masakazu Hatanaka,M. Maki,Hakan Caner,Jennifer L. Collins,(unknown),(unknown),Elizabeth A. Lunney,Sheryl J. Hays,Po‐wai Yuen	243
18	An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective (calpainyprotease inhibitorycalcium-binding proteinyproteaseyexcitotoxicity) 1996 ·Kevin Wang,Rathna Nath,Avigail Posner,Kadee J. Raser,(unknown),Iradj Hajimohammadreza,(unknown),(unknown),F Marcoux,Qizhuang Ye,Emiko Takano,Minoru Hatanaka,M. Maki,Lynne Collins,(unknown),(unknown),(unknown),Sheryl J. Hays,Po‐wai Yuen	1
19	Aurintricarboxylic acid is an inhibitor of mu- and m-calpain. 1995 ·PubMed ·Avigail Posner,Kadee J. Raser,Iradj Hajimohammadreza,Po‐wai Yuen,Kevin Wang	30
20	A short, stereospecific route to chiral trans-2,6-disubstituted quinuclidines 1989 ·Tetrahedron Letters ·E. J. Corey,Po‐wai Yuen	10

About Po‐wai Yuen

Po‐wai Yuen is a scholar working on Geriatrics and Gerontology, Cell Biology and Biological Psychiatry, having authored 24 papers that have together received 1.3k indexed citations. Recurring topics across this work include Calpain Protease Function and Regulation (10 papers), Neuroscience and Neuropharmacology Research (5 papers) and Sirtuins and Resveratrol in Medicine (4 papers). The work is most often cited by research in Cell Biology (686 citations), Geriatrics and Gerontology (65 citations) and Cellular and Molecular Neuroscience (295 citations). Po‐wai Yuen has collaborated with scholars based in United States, Japan and Poland. Frequent co-authors include Kevin Wang, Rathna Nath, Kadee J. Raser, Avigail Posner, Iradj Hajimohammadreza, Richard B. Gilbertsen, Robert V. Talanian, Daniel Stafford, Hamish Allen and Emiko Takano. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biochemical Journal and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact